×

SC17 - Trapdoors in Testicular Pathology



Evaluated by: Laura W. Lamps, M.D., UAMS Health, July 8, 2016
Original release date: March 17, 2016
Access to this course expires on: March 17, 2019
CME/SAMs 2.75

Course Description
The rarity and complexity of testicular tumors present unique challenges for pathologists. The spectrum of morphologic variation in testicular tumors is tremendous and poses a great challenge, especially in general surgical pathology practice because of limited exposure to these rare tumors. Even as specialists, genitourinary pathologists may deal with only a handful of cases on an annual basis. Correct diagnosis is the key in clinical management of many of these tumors where decisions of administration of chemotherapy are often made on pathological appearances. Additionally, inherited disorders may be associated with unique morphologic variants, making it extremely challenging to cater the management in terms of lifelong commitment for the patients and the clinicians. This course presents information directly relevant to diagnostic surgical pathologists and is based on evidence published in peer-reviewed journals. Both Indiana University School of Medicine and St. Bartholomew's Hospital have international and long-established reputations in testicular pathology, with unparalleled collections of tumors to share with the faculty. Material from these cases is utilized in providing examples of diagnostically difficult cases along with a detailed discussion of diagnostic dilemmas surrounding the specific entities including variants of seminoma, solid yolk sac tumor, dermoid cyst, cystic trophoblastic disease, variant Sertoli cell tumors, gonadoblastoma, rete carcinoma, and angiomyofibroblastoma. The case presentations cover histopathological features, differential diagnosis, adjuvant diagnostic techniques, patient management, and recent advances in the understanding of pathogenesis.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Accurately diagnose and identify the spectrum of morphologic variation in testicular tumors
  • Be familiar with the prognostic and treatment implications of their diagnoses
  • Have insight into recent advances in the understanding of the pathogenesis of these tumors.
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 2.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 2.75 SAM credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Daniel M. Berney, FRCPath, Muhammed Idrees, M.D.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.


Not A Member? Click Here